BACKGROUND	We hypothesized that low dose intradermal vaccination of the trivalent influenza vaccine ( TIV ) delivered by the MicronJet600 ( NanoPass Technologies , Israel ) would be non-inferior to the full dose intramuscular and mid dose Intanza ( ) vaccination in the elderly and the chronically ill adults .\